James Alan Smith - 01 Feb 2023 Form 3/A - Amendment Insider Report for Vaxxinity, Inc.

Role: Director
Signature: /s/ Rene Paula Molina, attorney-in-fact for James Alan Smith
Issuer symbol: VAXX on OTC
Transactions as of: 01 Feb 2023
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 28 Apr 2023, 17:56:23 UTC
Date Of Original Report: 10 Feb 2023
Next filing: 26 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VAXX	Class A common stock						8,058	01 Feb 2023	Direct
holding	VAXX	Class A common stock						54,202	01 Feb 2023	By IO Fund, LLC	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Remarks:

This Form 3 amendment is being filed to correct the original Form 3 filed on February 10, 2023, which included an incorrect number of shares owned by the reporting person in Table I due to an administrative error.